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Role of Solute Excretion in Prevention
of Norepinephrine-Induced Acute Renal Failure
R.W. SCHRIER, R.E. CRONIN, P. MILLER, A. deTORRENTE, T. BURKE,
AND R. BULGER
Denver, Colorado; Baltimore, Maryland
Infusion of 0.75 a g/kgbw/min norepinephrine (NE), for 40 minutes, into one renal artery in anesthe-
tized dogs, induced acute renal failure (ARF). Subsequently there was nearly complete reversal offunction
within 8 weeks. Isotonic saline volume expansion, or renal vasodilation plus diuresis by acetylcholine (into
renal artery: 20 p,g/min) did not protect against this type of ARF. Volume expansion with either 5 or 20
percent mannitol partly prevented thefall ofGFR 3 hours afterNE, this protection beingcorrelated with the
magnitude of the osmolar clearance at the time ofthe insult. IV furosemide (10 mg/kg + 10 mg/kg/h; fluid
losses replaced) afforded an even better protection. Proximal tubular necrosis in the"protected" kidneys was
as severe as in non-protected kidneys. Glomerular cell morphology (scanning electron microscopy) was not
altered by the 40-minute NE infusions. Functional "protection" appeared todepend on solute diuresis at the
time of insult.
INTRODUCTION
Analyzing measures that protect experimental animals from acute renal failure
(ARF) has been a useful deviceto studythe pathogenesis ofARF. Inusingpreventive
measures for this purpose, it is assumed that the protective maneuver blocks or alters
a pathogenic process that unopposed would lead to ARF. This approach, then, may
offer insights regarding the pathogenesis of a particular ARF model. Acute extracel-
lular fluid (ECF) volume expansion [1], renal vasodilators [2], induction of ECF
hypertonicity [3], and solute diuresis [4,5] have all been found useful in protecting
from experimental ARF. However, the markedly different models of ARF used in
these studies make it difficult to obtain a comprehensive picture of the individual
importance of each experimental maneuver in explaining the pathogenic lesion of
ARF.
The objectives of the present studies were twofold: (1) to develop a reproducible,
reversible experimental model of ARF resembling human ARF that would allow
systematic testing of the experimental procedures outlined above, and(2) to describe
the pathogenesis of the model based on evaluation of the protective influences.
METHODS
These studies were based upon a modification of a recently described model of
norepinephrine-induced ARF [6,7].
Chronic Studies
Experiments were performed on mongrel dogs of either sex weighing 22-32 kg.
Food was withheld for 18 hours and water was allowed ad libitum. On the day of
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All rights of reproduction in any form reserved.study, the animal was anesthetized (pentobarbital 30 mg/kgIV) and an angiographic
catheter inserted in the femoral artery was fluoroscopically guided into one renal
artery for infusion of norepinephrine (NE) (0.75 p g/kg/min). Followingthe infusion
the catheter was removed and the femoral artery ligated. Blood and urine studies
were obtained at regular intervals over the next 8 weeks.
Acute Clearance Studies
In anesthetized dogs, a retroperitoneal approach was used to catheterize both
ureters and renal veins, and one renal artery was isolated for placement of an
electromagnetic flow probe. During dissection, care was used to prevent damage to
the renal nerves. An angiographic catheter was then positioned in the renal artery
following a 60-90 minute equilibration period. The following protocols were
examined. Group I (untreated animals) received a 40-minute infusion of NE (0.75
pg/kg/ min) into one renal artery and were then studied for 3 hours. Group II was
volume expanded with 0.9 percent saline (0.75 ml/kg/min) for 30 minutes prior to
the NE infusion. Group III was volume expanded with 5 percent mannitol (0.75
ml/kg/min) and Group IV with 20 percent mannitol (0.2 ml/kg/min) for 30 minutes
prior to the NE infusion. Group V received acetylcholine(Ach) at 20 pg/mindirectly
into the renal artery beginning 30 minutes prior to the NE infusion. Group VI
animals received a furosemide bolus (10 mg/kg) and constant intravenous infusion
(10 mg/kg/hour) commencing 30 minutes prior to the NE infusion.
In a separate group of studies using micropuncture techniques, tubular pressure
changes were evaluated in animals from Group I and Group III. To prevent volume
depletion during the study, urine flow was matched with mannitol (Groups III and
IV) or isotonic saline (Group II, V, VI) infusion.
Light and electron microscopic studies on renal tissue were performed 24 hours
post NE infusion..
CHRONIC STUDIES
These studies were undertaken to assess the long-termfunctional characteristics of
a recently described model of ARF [7] that utilized a 2-hour intrarenal norepineph-
rine infusion (0.75 pg/kg/min) and compare it with a shorter 40-minute infusion.
Eight weeks post NE infusion a comparison between 4 kidneys infused for 2 hours
and 4 kidneys infused for 40 minutes showed marked oliguria(0.02 ± 0.2 ml/min vs.
0.56 ± 0.38 ml/min), severely reduced renal blood flow (10.0 ±0 ml/min vs. 209 ±67
ml/min), and marked reduction in renal mass (15.8 ± 1.5 gm vs. 50.2 ± 6.1 gm) with
the longer infusion. When the infused kidneys for 40 minutes were compared with
their own contralateral kidneys, there was no difference in renal weight but inulin
clearance and renal blood flow were both modestly impaired at 8 weeks post NE
infusion. These results clearly indicated thatthe40-minuteinfusionprovided abetter
model to study the pathogenesis of ARF than did the irreversible 2-hour model.
To more precisely define the natural history ofthis model, additional studies were
performed. Three weeks following unilateral nephrectomy, norepinephrine (0.75
pg/kg/min) was infused intrarenally for 40 minutes and serial studies were per-
formed over the next 8 weeks. Following the infusion, plasma urea nitrogen and
plasma creatinine rose from the control values of 24 ± 2.3 mg% and 2.2 ± 0.2 mg %,
respectively, to 106 ± 31 mg%/ and 9.6 ± 2.9 mg%o, respectively, on the seventh post-
infusion day with a return of both to near control levels by 8 weeks post in-
fusion. Two of nine animals remained oliguric post infusion and died from uremic
complications. Impaired renal concentration was notedduringthe course oftheARF
with afall inthe urine to plasmaratio ofcreatinine(U/P creatinine) from acontrol of
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197 ± 52 to 11 ±3 three hours post infusionwith a returnto approximately 38 percent
of control at 8 weeks. Although plasma renin activity rose acutely 3 hours post
infusion (9.0 ±2.4 ng/ml/hr to 25.6 ± 4.8 ng/ml/hr), the level returned to less than
control at 24 hours and remained low for the remainder ofthe 8-week study period.
Taken together, then, these chronic studies showed that a 40-minute intrarenal
norepinephrine infusion produced a model of ARF with reversible derangements in
renal function that bore considerable similarity to human ARF. The next series of
experiments explored events in the initiation phase of this model.
ACUTE CLEARANCE STUDIES
The specific aim of these experiments was to investigate the protective role in the
pathogenesis of NE-induced ARF of acute volume expansion, acute induction of
plasma hypertonicity, acutely increased renal blood flow and acutely induced solute
diuresis. In untreated animals (Group I) the norepinephrine infusion caused a
marked reduction in inulin clearance three hours post infusion (54.1 ± 6.5 ml/minto
1.3 ± 1.3 ml/min). Compared with Group I, volume expansionwith saline(Group II)
afforded no protection when inulin clearances 3 hours post infusion were compared
(1.3 ± 1.3 ml/min vs. 3.3 ± 1.5 ml/min,p = NS). In contrast, whencompared to Group
I, animals pre-treated with 5 percent mannitol (Group III) or 20 percent mannitol
(Group IV) and having similar volume expansion (25 percent) to Group II showed
significantly less reduction of inulin clearance at 3 hours (9.2 ± 2.5 ml/min and 16.6
± 3.9, respectively, p < .01 in both cases). In a separate group of animals from
Groups I-IV similarly treated but not studied until 24 hours post infusion, inulin
clearance remained severely reduced in Groups I and II but had recovered even
further in Groups III and IV to levels greater than 50 percent of control values. The
difference in the degree of recovery seen in Groups III and IV was not different
indicating that ECF hypertonicity was not a critical determinant of protection. For
Groups II-IV, inulin clearance 3 hours post infusion correlated positively with the
magnitude of osmolar clearance at the time of the insult (r = .593,p < 0.001) but not
with the corresponding renal blood flow or inulin clearance.
To test the importance of renal vasodilatation and a solute diuresis, renal blood
flow was increased to comparable degrees(20 percent) by either intrarenal acetylcho-
line (20 p g/min) (Group V) or intravenous furosemide(10 mg/kg/hr after 10 mg/kg
bolus) (Group VI). At 3 hours post norepinephrine, the inulin clearance of the
infused kidney had returned to 74 percent + 13 percent of the control kidney
(p < .001) in Group VI. In contrast, kidneys were not significantly protected in Group
V. As with Group III and Group IV, protection with furosemide correlated closely
with the rate of solute excretion.
In untreated animals (Group I) pressure measurements 2 hours post infusion inthe
proximal tubule (PT) were back to control but inulin clearance was severely reduced
(19 ± 2 ml/min to 2± 2 ml/min, p < .001); similarfindings persisted at 24 hours post
infusion. In contrast, animals pretreated with 5 percent mannitol (Group III) had a
significant rise in PT pressure above control values at 2 hours post infusion (25
± 2 mmHg to 38 ± 5 mmHg) associated with an inulin clearance significantly higher
than in untreated animals (5 ± 2 ml/min, p < .05). At 24 hours post infusion inulin
clearance in the mannitol group had risen further to 18 ± 5 ml/min, as inulin
clearance remained low in the untreated animals.
Light microscopic studies in Groups I-IV showed uniform proximal tubular
necrosis in all groups regardless of the severity of the functional lesion. Ofinterest,
proximal tubular lumens were filled with cellular debris and eosinophilic material in
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FIG. 1. Scanning electron micrograph ofglomerular ':3.
capillary loop 24 hours post norepinephrine infusion.
Interdigitating epithelial podocytes are normal. X 2500.
Groups I and II while tubular lumens in Groups III and IV were open despite
extensive destruction of the proximal tubular cells. Unlike the results in studies with
the 2-hour NE model [7], scanning electron microscopy failed to demonstrate an
alteration in glomerular epithelial cell morphology in any group (Fig. 1).
DISCUSSION
The studies described here have characterized renal functional and histological
features of the initiation phase of norepinephrine-induced ARF in the dog. Unlike
the 2-hour intrarenal norepinephrine infusion model [6,7], which produced irreversi-
ble functional and anatomical renal damage, this 40-minute norepinephrine infusion,
when studied over an 8-week period, was characterized by reversible alterations in
renal excretion, renal concentrating ability and plasma renin activity similar to those
seen in clinical ARF. Thus, this 40-minute norepinephrine model offered a frame-
work upon which to investigate the initiation phase of ARF, as was done here, and
may prove a useful tool in characterizing the maintenance and recovery phases of
ARF as well.
These studies document a protective effect of mannitol and furosemide on the
severity of the renal injury produced by a 40-minute intrarenal norepinephrine
infusion. While mannitol and furosemide can induce many functional changes,
including alterations in extracellular fluid compartment size, renal blood flow and
renal excretion, the common ability to promote a brisk solute diuresis seen in Groups
III, IV, and VI was the only factor that correlated with protection against ARF.
Moreover, protection against ARF did not correlate with ECF volume expansion,
ECF osmolality, proximal tubular necrosis, glomerular abnormalities on electron
microscopy or the level of GFR or RBF prior to the NE insult. Although acute
volume expansion with isotonic saline or isotonic mannitol has provided some
protection in rats with glycerol-induced ARF [8], no beneficial effect from acute
volume expansion was apparent in the present study. Also, plasma hypertonicity
resulting from the infusion of hypertonic mannitol afforded no greater protection
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against acute renal failure than isotonic mannitol in this study. The failure ofplasma
hypertonicity resulting from 20 percent mannitol to afford greater protection than 5
percent mannitol, fails to lend support to the cell swelling theory where extracellular
fluid hypertonicity presumably prevents post-ischemic capillary endothelial cell
swelling and "no-reflow" in the rat [3].
It appears, then, that the renal excretory status prior to renal injury, namely the
osmolar clearance rate, was the critical determinant of protection in this study. The
need for high urine flow rates to prevent ARF has previously been stressed in a
methemoglobinferrocyanide model of ARF in the rat using a number of osmotically
active agents [4]. The importance of a solute rather than water diuresis in producing
these high urine flows was confirmed by the failure of rats with hereditary diabetes
insipidus to be protected against glycerol-induced ARF despite their massive volumes
of dilute urine [1]. A recent study has challenged the ideathat the protective effect of
chronic saline loading in experimental ARF is due to suppression ofintrarenal renin
levels [5]. Rats chronically treated with furosemide and saline infusions achieved
protection from mercuric chloride-induced ARF to a degree similar to that seen in
rats given DOCA and saline drinking water. However, intrarenal renin levels were
only slightly depressed in the furosemide group compared to the marked depression
in DOCA-saline rats thereby dissociating protection from renin suppression. In this
study, also, the factor ofprimaryimportance in protection appeared to be the level of
osmotic diuresis.
The precise mechanism by which high solute excretion affords protection against
norepinephrine-induced ARF is unknown but the clearance, micropuncture, and
histological data presented here are most consistent with an intratubular action to
prevent intratubular obstruction. Recent micropuncture studies in ischemia-induced
ARF in the rat showing marked proximal tubular pressure elevations in the
immediate post-ischemia period are compatible with an important role for tubular
obstruction in other ischemic models ofARF. Lastly, inregard to the protection seen
in the present study with mannitol and furosemide, it is noteworthy that both agents
normally cause a marked rise in proximal tubular pressure [9,10], thus offering a
possible mechanism for any beneficial effect in attenuating intratubular obstruction.
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